Department of Quantitative Biomedicine

The DQBM fosters research and education at the interface of biomedical research, biotechnology, and computational biomedicine to develop the foundations of next-generation precision medicine.

Grid containing content elements

Weiterführende Informationen

News

15 Sep 2023

DQBM and the Institute for Implementation Science in Healthcare (IfIS) launch BME337: "Introduction to Digital Health"

More about DQBM and the Institute for Implementation Science in Healthcare (IfIS) launch BME337: "Introduction to Digital Health"
31 Aug 2023

The Bodenmiller group develops multielement Z-tag imaging by X-ray fluorescence microscopy

More about The Bodenmiller group develops multielement Z-tag imaging by X-ray fluorescence microscopy
31 Aug 2023

The Bodenmiller group develops DNA-barcoded signal amplification for imaging mass cytometry

More about The Bodenmiller group develops DNA-barcoded signal amplification for imaging mass cytometry
30 Aug 2023

The Kümmerli group explores bacterial strain-specific resistance evolution

More about The Kümmerli group explores bacterial strain-specific resistance evolution
11 Aug 2023

The Menze group develops a method to generate accurate synthetic CT images from MRI data

More about The Menze group develops a method to generate accurate synthetic CT images from MRI data
1 Aug 2023

Michael Krauthammer takes over the DQBM Directorship from Bernd Bodenmiller per 01.08.2023

More about Michael Krauthammer takes over the DQBM Directorship from Bernd Bodenmiller per 01.08.2023

Department of Quantitative Biomedicine

Quicklinks und Sprachwechsel

Main navigation

Department of Quantitative Biomedicine

Grid containing content elements

Bodenmiller Group

Joller Group

Krauthammer Group

Kümmerli Group

Menze Group

Polymenidou Group

Education - DQBM teaching

About us

Outreach - Scientifica 2023

Weiterführende Informationen

News

DQBM and the Institute for Implementation Science in Healthcare (IfIS) launch BME337: "Introduction to Digital Health"

The Bodenmiller group develops multielement Z-tag imaging by X-ray fluorescence microscopy

The Bodenmiller group develops DNA-barcoded signal amplification for imaging mass cytometry

The Kümmerli group explores bacterial strain-specific resistance evolution

The Menze group develops a method to generate accurate synthetic CT images from MRI data

Michael Krauthammer takes over the DQBM Directorship from Bernd Bodenmiller per 01.08.2023